期刊文献+

杀菌/渗透增强蛋白功能区抗菌肽与内毒素亲和性的SPR技术检测 被引量:1

SPR detection of affinity of antibacterial peptides in bactericidal/permeability-increasing protein domain for endotoxin
下载PDF
导出
摘要 目的:研究杀菌/渗透增强蛋白(BPI)不同功能区抗菌肽与内毒素(LPS)结合的能力。方法:设计、合成来自杀菌/渗透增强蛋白N端不同功能区的3段抗菌肽,分别为BPI22-36、BPI85-99和BPI147-161,将其固定于CM5蛋白质芯片上,使用表面等离子共振(SPR)仪检测3种抗菌肽与LPS和类脂A(Lipid A)相互作用的情况。结果:3种抗菌肽中,BPI147-161与LPS和Lipid A结合的能力最强,BPI85-99次之,但BPI22-36与其不结合;BPI147-161与Lipid A的亲和常数KA为1.12×106L/mol,相比,多黏菌素B(PMB)的亲和常数KA为5.58×106L/mol。结论:来自杀菌/渗透增强蛋白的抗菌肽BPI147-161能有效地中和内毒素,这可能为败血症休克的治疗提供一种新的策略。 AIM: To study the affinity of endotoxin for three antibacterial peptides derived from N-terminal domain of bactericidal/permeability-increasing protein(BPI).METHODS: To design and synthesize three peptides from N-terminal domain of BPI,BPI22-36,BPI85-99 and BPI147-161.Surface plasmon resonance(SPR) was used to monitor the interaction between LPS/lipid A and the peptides and polymyxin B(PMB) immobilized on CM5 sensor chip.RESULTS: In three peptides,BPI147-161 was proved to have a best binding capacity with LPS/lipid A,followed by BPI85-99,but BPI22-36 could not interact with LPS/lipid A.The affinity constant KA of BPI147-161 with lipid A was 1.12×106 L/mol.In contrast,the KA of PMB was 5.58×106L/mol.CONCLUSION: The rusults suggests that the peptid BPI147-161 from BPI effectively neutralize endotoxin and probably provide a novel treatment method for septic shock.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第11期1143-1145,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 北京市优秀人才培养资助项目(20071D0501800245) 北京市属高等学校人才强教计划资助项目(PHR201008411)
关键词 杀菌/渗透增强蛋白 内毒素 (类)脂质A 相互作用 表面等离子共振技术 bactericidal/permeability-increasing protein endotoxin lipid A interaction surface plasmon resonance
  • 相关文献

参考文献7

  • 1Beamer LJ,Carroll SF,Eisenberg D.The BPI/LBP family of protein:a structural analysis of conserved regions[J].Protein Sci,1998,7:906-914.
  • 2Abrahamson SL,Wu HM,Williams RE,et al.Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability increasing protein:implications in biolngical activity[J].J Biol Chem,1997,272:2149-2155.
  • 3Beamer LJ,Carroll SF,Eisenberg D.Crystal structure of human BPI and two bound phespholipids at 2.4 angstrom resolution[J].Science,1997,276:1861-1864.
  • 4Rich RL,Myszka DG.BIAcore J:a new platform for routine biomolecular interaction analysis[J].J Mol Recognit,2001,14(4):223-228.
  • 5Shoji H,Tani T,Hanasawa K,et al.Extracorporeal immobilized fiber endotoxin removal by polymyxin B cartridge:designing and antiendotoxin efficacy in the clinical application[J].Ther Aphere,1998,2(1):3-12.
  • 6Shoji H.Extracorporeal endotoxin removal for the treatment of sepsis:endotoxin adsorption cartridge(toraymyxin)[J].Ther Aphere Dial,2003,7(1):108-114.
  • 7Nilsson A,Fant C,Nydén M,et al.Lipopolysaccharide removal by a peptide-functionalized surface[J].Colloids Surf B,2005,40:99-106.

同被引文献22

  • 1Li J, Xu X, Xu C, et al. Anti-infection peptidomics of amphibian skin[ J ]. Mol Cell Proteomics, 2007,6 ( 5 ) : 882-894.
  • 2Hancock RE.Peptide antibiotics [ J ]. Lancet, 1997,349 (9049) : 418-422.
  • 3Raman-Garcia S, Mikut R, Ng C, et al. Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides [ J ]. Antimicrob Agents Chemother, 2013,57 (5) : 2295-2303.
  • 4Wieprecht T, Apostolov O, Beyermann M, et al.Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects [J]. Biochemistry, 2000,39(2) :442-452.
  • 5Gelhaus C, Jacobs T, Andra J, et al. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum [J]. Antimicrob Agents Chemother, 2008,52(5) : 1713-1720.
  • 6Noore J, Noore A, Li B. Cationic antimicrobial peptide LL-37 is effective against both extra- and intraeellular Staphylococcus anreus [J]. Antimierob Agents Chemother, 2013,57(3): 1283-1290,.
  • 7Zhu C, Tan H, Cheng T, et al. Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation [J]. J Surg Res,2013,183(1) :204-213.
  • 8Hirt H, Gorr SU.Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomanas aeru-nosa [J]. Antimicrob Agents Chemother, 2013,57 ( 10 ) : 4903 -4910.
  • 9Saiman L, Tabibi S, Starner TD, et al. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis [J].Antimicrob Agents Chemother, 2001,45 ( 10 ) : 2838-2844.
  • 10Kalita A, Verma I, Khuller GK.Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy [J]. J Infect Dis, 2004,190(8 ): 1476-1480.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部